These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 28900871)

  • 1. Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis.
    Wang J; Zhang C; Liu Z; Bai Y
    J Int Med Res; 2021 Apr; 49(4):3000605211005972. PubMed ID: 33878914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.
    Davenport MS; Perazella MA; Yee J; Dillman JR; Fine D; McDonald RJ; Rodby RA; Wang CL; Weinreb JC
    Kidney Med; 2020; 2(1):85-93. PubMed ID: 33015613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention.
    Pan HC; Wu XH; Wan QL; Liu And BH; Wu XS
    Exp Biol Med (Maywood); 2018 Aug; 243(12):970-975. PubMed ID: 30299175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy.
    Wong GT; Irwin MG
    Br J Anaesth; 2007 Oct; 99(4):474-83. PubMed ID: 17681968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention.
    Hossain MA; Costanzo E; Cosentino J; Patel C; Qaisar H; Singh V; Khan T; Cheng JS; Asif A; Vachharajani TJ
    Saudi J Kidney Dis Transpl; 2018; 29(1):1-9. PubMed ID: 29456202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Contrast-Induced Nephropathy in Patients with Multiple Myeloma Undergoing Contrast-Enhanced Procedures.
    Crowley MP; Prabhakaran VN; Gilligan OM
    Pathol Oncol Res; 2018 Oct; 24(4):915-919. PubMed ID: 28900871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
    Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
    AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
    Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
    Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
    Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of contrast-induced nephropathy in hospitalised patients with cancer.
    Cicin I; Erdogan B; Gulsen E; Uzunoglu S; Sut N; Turkmen E; Kodaz H; Ustundag S
    Eur Radiol; 2014 Jan; 24(1):184-90. PubMed ID: 24220752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy: pharmacology, pathophysiology and prevention.
    Geenen RW; Kingma HJ; van der Molen AJ
    Insights Imaging; 2013 Dec; 4(6):811-20. PubMed ID: 24092564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney disease and multiple myeloma.
    Heher EC; Rennke HG; Laubach JP; Richardson PG
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):2007-17. PubMed ID: 23868898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis.
    McDonald JS; McDonald RJ; Comin J; Williamson EE; Katzberg RW; Murad MH; Kallmes DF
    Radiology; 2013 Apr; 267(1):119-28. PubMed ID: 23319662
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.